Brian Schwartz

Brian Schwartz M.D. serves as our Head of Clinical Development. He has significant experience in a drug development spanning several therapeutic areas including oncology, hematology, dermatology, neurology and rare diseases. During the past decade Brian has served as Senior Vice President, Head of Research & Development and Chief Medical Officer of ArQule Inc., which was acquired for $2.7bn by Merck & Co. in 2020. Prior to ArQule Inc., Brian was CMO at Ziopharm, having previously held several senior leadership roles at Bayer and LEO Pharma. Brian is a Board Member of several companies and acts as an independent consultant for numerous biotech companies. Brian received his medical degree from the University of Pretoria, South Africa, completed a fellowship at the University of Toronto, Canada and practiced medicine prior to his career in the biopharmaceutical industry.